New Appointment: Dr. Paul Goepfert Takes the Helm as Principal Investigator for AIM’s Innovative Avian Influenza Vaccine Trial: Ampligen and FluMist Combination
Exploring the Future of Influenza Vaccines: Ampligen as a Game-Changer In the ever-evolving world of medical research, scientists are constantly seeking innovative solutions to improve the effectiveness of vaccines. One such intriguing development is the proposed study of Ampligen as a vaccine adjuvant for influenza strains. Let’s delve into this fascinating topic and explore its…